Semaglutide: Licenced Supplier - Bogor

The oral medication Semaglutide causes delayed stomach emptying. Patients should closely follow the administration guidelines while using oral drugs with semaglutide. Patients taking Semaglutide may develop anti-semaglutide antibodies, which is consistent with the potential immunogenic properties of protein and peptide medications. The ability to detect the formation of antibodies depends heavily on the assay's sensitivity and specificity. The documented incidence of antibodies positive in a test may also depend on a number of factors, including the assay's methodology, sample handling, the timing of sample collection, concurrent medications, and underlying disorders.